Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q4 FY2025 Earnings Presentation
36 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, May 26, 2025
Slide 1: Cover letter to stock exchanges
May 26, 2025 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 543950
Slide 2: Q4 & FY25 Earnings Presentation
Q4 & FY25 Earnings Presentation May 26, 2025
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t
Slide 4: Q4 & FY25 Performance Highlights
Q4 & FY25 Performance Highlights
Slide 5: FY25 Performance Summary
FY25 Performance Summary Bed Capacity* Occupancy ARPOB ALOS 2,300+ beds 61% Rs. 30,829 4.33 +7% YoY +8% YoY Revenue EBITDA EBITDA Margin PAT Rs. 8,805 mn Rs. 2,202 mn 25.0% Rs. 1,306 mn +31% YoY +22% YoY -182bps YoY +14% YoY Operating Cash Flows Cash Conversion Ratio1 Net Cash ROCE# Rs. 1,496 mn 68%
Slide 6: Q4 FY25 Performance Summary
Q4 FY25 Performance Summary Revenue EBITDA EBITDA Margin Rs. 2,318 mn Rs. 570 mn 24.6% +30% YoY +23% YoY -157bps YoY PBT PAT Operational Beds Rs. 485 mn Rs. 387 mn* 1,605 beds +21% QoQ | +10% YoY +27% QoQ | +1% YoY Occupancy ARPOB ALOS 61% Rs. 31,441 4.20 +4% YoY +7% YoY *Change in PBT and PAT facto
Slide 7: Financial Highlights
Financial Highlights Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% +30% +31% 3000 2994 28% 25.0% 1000 28% 2988 2982 2976 99 5 2970 2964 2958 26.2% 99 0 2952 2946 2940 98 5 2934 2928 98 0 2922 2916 2910 975 2904 2898 970 2892 2886 27% 96 5 27% 2880 2874 2868 96 0 2862 2856 26.8% 95 5 2850 2844 2838 25.1%
Slide 8: Operational Highlights
Operational Highlights IPD & OPD Volumes (in ‘000s) Occupancy (%) 100 % 100 % IPD Volume OPD Volume 90% 447 90% 100 0 100 0 80% 80% 120 376 70% 109 70% 140 500 500 60% 90 60% 120 50% 50% 100 381 0 40% 0 327 40% 80 92 103 60% 61% 61% 57% 54% 30% 78 30% 60 -500 -500 20% 20% 40 10% 66 10% 20 0 12 17 18
Slide 9: Diversifying revenues across hospitals (FY25)
Diversifying revenues across hospitals (FY25) Noida Extension Noida Extension 32% 37% Faridabad, Rs. 2,149 mn Rs. 3,231 mn Jhansi- 5% Orchha Rs. 436 mn 5% Jhansi- Rs. 360 mn FY24 Orchha FY25 Rs. 6,705 mn 7% Rs. 8,805 mn Rs. 606 mn Noida, 28% Noida, Rs. 1,857 mn 20% Greater Noida Rs. 1,817 mn Greater
Slide 10: Diversifying revenues across hospitals (Q4 FY25)
Diversifying revenues across hospitals (Q4 FY25) Noida Extension Noida Extension 35% 36% Rs. 619 mn Faridabad, Rs. 827 mn Jhansi- 9% Orchha Rs. 212 mn 6% Rs. 104 mn Q4 FY24 Jhansi- Q4 FY25 Rs. 1,778 mn Orchha Rs. 2,318 mn 7% Noida, Rs. 160 mn 26% Noida, Rs. 469 mn 19% Greater Noida Greater Noida Rs.
Slide 11: Expanding high value specialties across hospitals
Expanding high value specialties across hospitals Diverse mix of specialties at all hospitals Noida extension hospital registered highest share of super specialties FY2025 19% 11% 11% 10% 10% 8% 7% 6% 5% 4% 4% 5% Pediatrics, 3% Others, 4% Oncology Gynecology 19% 6% Pulmonology, 6% FY2024 28% 10% 10%
Slide 12: Operational Highlights for the quarter
Operational Highlights for the quarter Capacity Expansion Improvement in occupancy across our hospitals • Successful registration and possession of hospital in New Delhi (~300+ beds) and • Despite bed additions, occupancy levels acquisition of majority stake in Faridabad improves to 61% in FY25, com
Slide 13: Update on Acquisitions
Update on Acquisitions Expanding footprint in New Delhi & Faridabad – Successful possession of both the assets, operationalization in Q1 FY26 Yet to commence Established Multi-specialty hospital ❖ Strategic collaboration agreement ❖ Successful bidding for MD City Multi-specialty hospital for ~60% st
Slide 14: Initiatives towards attracting Medical Value Travel
Initiatives towards attracting Medical Value Travel Meetings with key Govt Meetings with key Govt African Students Union Health camp and local Health camp and local officials and Private officials and Private - informative and doctors meet in doctors meet in hospitals in Nigeria hospitals in Nigeria
Slide 15: Profit & Loss Summary
Profit & Loss Summary Change Change Change Particulars (Rs mn) Q4FY25 Q4FY24 Q3FY25 FY25 FY24 YoY QoQ YoY Revenue from Operations 2,318 1,778 30% 2,192 6% 8,805 6,705 31% Medical Consumables & Pharmacy 465 375 24% 421 11% 1,785 1,333 34% Employee Expenses 438 319 38% 426 3% 1,625 1,170 39% Other Exp
Slide 16: Balance Sheet
Balance Sheet Particulars (Rs mn) Mar-25 Mar-24 Particulars (Rs mn) Mar-25 Mar-24 Shareholders Equity 16,371 8,743 Fixed Assets (incl. Goodwill) 8,198 4,405 Borrowings 41 831 Right to Use Assets 74 14 Lease Liabilities 75 16 Financial Assets 53 243 Trade Payables 291 292 Inventories 210 81 Other fin
Slide 17: At a Glance
At a Glance
Slide 18: Leading Super specialty hospital in North India
Leading Super specialty hospital in North India One-stop destination for patient needs providing all levels of 7 11 87% healthcare services from primary to tertiary Hospitals* Center of Excellence Beds in Metros* 2024 2019 Noida Extension 2,300+ Rs. 30,829 61% 450 beds Bed Capacity* ARPOB (FY25) Occ
Slide 19: Our Journey
Our Journey Growing presence across regions and services Established our first Expansion of our first Acquisition of 4th hospital - Acquired 5th hospital – hospital in Greater hospital, Greater Noida Jhansi Orchha hospital 200 beds in Gr. Faridabad; Noida hospital, to 400 beds adding 305 beds, pursu
Slide 20: Our Hospitals
Our Hospitals Built on foundation of talent, trust, technology, service and infrastructure Diversified revenue mix Greater Noida Jhansi - Greater across hospitals (FY25) Hospitals Noida Noida Extension Orchha Faridabad Faridabad Year of Operation 2010 2013 2019 2022 2024 5% Beds Capacity 400 250 450
Slide 21: Our Mature Hospitals
Our Mature Hospitals 65% Occupancy Greater Noida Provides a wide spectrum of super specialty services in the field of 2010 Incorporated Rs.34,605 ARPOB cardiology, cardiovascular and thoracic surgery, neurology, 400 Beds; 112 ICU Beds neurosurgery, urology, nephrology, oncology, gastroenterology etc
Slide 22: Our New Hospitals
Our New Hospitals 50% Jhansi – Occupancy Hospital in Jhansi-Orchha-Gwalior region, has Orchha infrastructure to operate all the major super specialties Rs.13,218 ARPOB 2022 Acquisition Acquired in FY22 305 Beds; 76 ICU Beds 3.95 days ALOS 38% Acquired in 2024, a newly built hospital with latest Grea
Slide 23: Healthcare Delivery Market in India is at Nascent stage
Healthcare Delivery Market in India is at Nascent stage Indian hospital market to grow at a CAGR of 10-12% to reach INR 10tn by FY28 Globally India has one of the lowest bed density/10,000 population 70 (INR tn) 50 9.4-9.8 27 6.3 2.6 26 3.9 1.8 25 1.3 7.2 4.5 24 2.6 20 FY19 FY24 FY28P 15 IPD OPD 9 W
Slide 24: North India - Underserved market with huge growth potential
North India - Underserved market with huge growth potential North India hospital market is expected to grow at a CAGR of 12-14%... …Growing at a faster rate than the overall industry (INR tn) 9-11% 10-12% (INR tn) 3.9 6.3 9.4-9.8 3.1-3.2 10-12% 11-13% 22.5-23.5% 22-24% 22-25% 9-11% 10-12% 1.9-2.0 11
Slide 25: Proximity to international airports to fuel medical tourism
Proximity to international airports to fuel medical tourism India’s medical tourism industry has been growing ~45% of the international patients travel to Delhi-NCR 40% Indira Gandhi Int. Airport Noida Extension 7.2 - 7.4 (~42 km from IGI; 7.0 Model Town, Delhi 58 km from Jewar) 6.4 6.4 (~24 km from
Slide 26: Core strategies driving growth
Core strategies driving growth Optimizing Infrastructure Enhancing occupancy and ARPOB across our hospitals 01 Capacity Addition 02 Greenfield and brownfield expansion Leverage Technology 03 Advanced and high-end medical equipment and technology 04 Clinical Expertise Attracting best talent to drive
Slide 27: Optimizing existing infrastructure
Optimizing existing infrastructure Mature hospitals New hospitals Total 66% 63% 61% Occupancy (%) 55% 54% 50% 50% 45% 47% Improve 42% 42% Diversifying customer specialties service 23% 8% NM NM FY21 FY22 FY23 FY24 FY25 Our 5-fold approach to optimize 34,417 existing infra 29,646 28,571 30,829 Optimiz
Slide 28: Capacity addition - greenfield and brownfield expansion
Capacity addition - greenfield and brownfield expansion Capacity addition trend and roadmap ahead Operational Beds New bed addition Planned bed addition Target bed capacity ~3,000 Operationalize 450* by Q1 FY26 Operationalize ~200-300 by Q1 FY26 ~400 200 ~300 305 450 May-24 650 Apr-22 May-19 Noida E
Slide 29: Advanced and high-end medical equipment and technology
Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce medical technology and state-of-the-art equipment Complex Kidney, Liver & Bone Robotic Surgeries – Marrow Transplant DaVinci, Mako & Cuvis Rad
Slide 30: Attracting best talent to drive super specialties
Attracting best talent to drive super specialties Strategic initiatives aimed to ease attrition Integrating talent from First mover advantage in well-established allied building out network across workforce Tier II/III cities ❑ Introduced DNB program across 13 specialties in 3 of the hospitals ❑ DNB
Slide 31: Proven record of consistent financial performance (1/2)
Proven record of consistent financial performance (1/2) Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 29.3% 3000 2994 30% 2988 2982 2976 2970 2964 2958 2952 2946 2940 2934 27.6% 2928 2922 2916 2910 2904 2898 29% 2892 2886 2880 2874 2868 2862 2856 26.8% 2850 2844 2838 2832 2826 2820 2814 2808 2802 279 6 2
Slide 32: Proven record of consistent financial performance (2/2)
Proven record of consistent financial performance (2/2) RoCE (%) Net Worth (Rs mn) 0.27 0.26 0.25 2000 0 0.24 ROCE temporarily dipped 16,371 0.23 0.22 0.21 due to fund raise - 0.2 0.19 15000 reflects ongoing 0.18 29% 0.17 integration of 0.16 28% 0.15 27% 0.14 acquisitions & medical 8,743 0.13 10000
Slide 33: Consistent performance across operational parameters
Consistent performance across operational parameters Occupancy (%) IPD/OPD Revenue (in ‘000s) 1 0.9 IPD Revenue OPD Revenue 8,805 1000 0.8 6,705 90 00 89 00 1,009 88 00 0.7 8700 86 00 85 00 84 00 8300 8200 8100 5,203 80 00 7900 7800 7700 50 0 80 00 7600 7500 7400 730 0 720 0 7100 0.6 7000 69 00 4,00
Slide 34: Awards and Accreditations
Awards and Accreditations 2020 2021 2022 2023 2024 ➢ Awarded 1st in ➢ Covid Thank You award ➢ 5-star grading by ➢ Awarded UP Ratan ➢ Awarded Best Brand for Swachhta Ranking (for by Niva Bupa Infomerics Analysts & Samman by Dainik Excellence in Healthcare quarter ended Sep 2019) ➢ Accreditation from
Slide 35: Experienced board and leadership team
Experienced board and leadership team Promila Bhardwaj Dr. Ajay Kumar Tyagi Independent Director Chairman & Whole-time Director 35+ yrs of experience 17+ yrs of experience Bachelor of arts, Master’s of arts in English, philosophy in social Bachelor of medicine, surgery, and diploma in orthopaedics s
Slide 36: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital and Trauma Care Services — Q4 FY2025 Earnings Presentation on 6ix